ScoreWhy is Anhui Anke Biotechnology (Group) Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 8.77% and Operating profit at 13.68% over the last 5 years
2
The company has declared Negative results for the last 4 consecutive quarters
- ROCE(HY) Lowest at 16.5%
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.23 times
3
With ROE of 16.56%, it has a fair valuation with a 4.22 Price to Book Value
- Over the past year, while the stock has generated a return of 3.23%, its profits have fallen by -25.2%
- At the current price, the company has a high dividend yield of 2
4
Underperformed the market in the last 1 year
- The stock has generated a return of 3.23% in the last 1 year, much lower than market (China Shanghai Composite) returns of 15.17%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Anhui Anke Biotechnology (Group) Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Anhui Anke Biotechnology (Group) Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Anhui Anke Biotechnology (Group) Co., Ltd.
2.41%
-0.05
40.12%
China Shanghai Composite
15.17%
1.02
14.86%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.77%
EBIT Growth (5y)
13.68%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.68
Tax Ratio
10.50%
Dividend Payout Ratio
57.82%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
31.01%
ROE (avg)
18.43%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
4.22
EV to EBIT
22.85
EV to EBITDA
19.29
EV to Capital Employed
5.45
EV to Sales
6.23
PEG Ratio
NA
Dividend Yield
2.04%
ROCE (Latest)
23.86%
ROE (Latest)
16.56%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -0.12% (YoY
CASH AND EQV(HY)
Highest at CNY 2,665.98 MM
NET SALES(Q)
Highest at CNY 670.4 MM
-5What is not working for the Company
ROCE(HY)
Lowest at 16.5%
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.23 times
Here's what is working for Anhui Anke Biotechnology (Group) Co., Ltd.
Net Sales
Highest at CNY 670.4 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Cash and Eqv
Highest at CNY 2,665.98 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -0.12% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Anhui Anke Biotechnology (Group) Co., Ltd.
Inventory Turnover Ratio
Lowest at 2.23 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
